(Q24235500)

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

18-Month mortality and perinatal exposure to zidovudine in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: its role in preventing HIV infection in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Antiretroviral regimens in pregnancy and breast-feeding in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Diethylstilbestrol revisited: a review of the long-term health effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Single-dose nevirapine and drug resistance: the more you look, the more you find

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Preventing mother-to-child transmission of HIV—protecting this generation and the next

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Antiretroviral therapies in women after single-dose nevirapine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

HIV transmission through breastfeeding: a study in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

AIDS across Europe, 1994-98: the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Antiretroviral treatment for children with peripartum nevirapine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Maternal vitamin A deficiency and mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Antiretroviral therapy and management of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Meeting international goals in child survival and HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Levels and trends in child mortality, 1990-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Protecting the Next Generation — Eliminating Perinatal HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

Risk factors for mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076--results and treatment recommendations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

[Clinical and laboratory evolution of children born to HIV positive mothers]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003510.PUB3

7 January 2021

10.1002/14651858.CD003510.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1748168

1748168

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference